Rapid review for the anti-coronavirus effect of remdesivir.Drug Discov Ther. 2020; 14(2):73-76.DD
Abstract
The outbreak of SARS-CoV-2 rapidly spread across China and worldwide. Remdesivir had been proposed as a promising option for treating coronavirus disease 2019 (COVID-19). We provided a rapid review to critically assess the potential anti-coronavirus effect of remdesivir on COVID-19 and other coronaviruses based on the most up-to-date evidence. Even though remdesivir was proposed as a promising option for treating COVID-19 based on laboratory experiments and reports from compassionate use, its safety and effect in humans requires high-quality evidence from well-designed and adequately-powered clinical trials for further clarification.
Links
MeSH
Adenosine MonophosphateAlanineAnimalsAntiviral AgentsBetacoronavirusCOVID-19Clinical Trials as TopicCoronavirus InfectionsDrug Evaluation, PreclinicalHumansMiddle East Respiratory Syndrome CoronavirusPandemicsPneumonia, ViralSevere acute respiratory syndrome-related coronavirusSARS-CoV-2COVID-19 Drug Treatment
Pub Type(s)
Journal Article
Review
Language
eng
PubMed ID
32378648
Clinical Trial Links
Citation
Li, Ziyi, et al. "Rapid Review for the Anti-coronavirus Effect of Remdesivir." Drug Discoveries & Therapeutics, vol. 14, no. 2, 2020, pp. 73-76.
Li Z, Wang X, Cao D, et al. Rapid review for the anti-coronavirus effect of remdesivir. Drug Discov Ther. 2020;14(2):73-76.
Li, Z., Wang, X., Cao, D., Sun, R., Li, C., & Li, G. (2020). Rapid review for the anti-coronavirus effect of remdesivir. Drug Discoveries & Therapeutics, 14(2), 73-76. https://doi.org/10.5582/ddt.2020.01015
Li Z, et al. Rapid Review for the Anti-coronavirus Effect of Remdesivir. Drug Discov Ther. 2020;14(2):73-76. PubMed PMID: 32378648.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Rapid review for the anti-coronavirus effect of remdesivir.
AU - Li,Ziyi,
AU - Wang,Xiaojie,
AU - Cao,Donglin,
AU - Sun,Ruilin,
AU - Li,Cheng,
AU - Li,Guowei,
PY - 2020/5/8/entrez
PY - 2020/5/8/pubmed
PY - 2020/5/10/medline
KW - COVID-19
KW - SARS-CoV-2
KW - effect
KW - remdesivir
KW - safety
SP - 73
EP - 76
JF - Drug discoveries & therapeutics
JO - Drug Discov Ther
VL - 14
IS - 2
N2 - The outbreak of SARS-CoV-2 rapidly spread across China and worldwide. Remdesivir had been proposed as a promising option for treating coronavirus disease 2019 (COVID-19). We provided a rapid review to critically assess the potential anti-coronavirus effect of remdesivir on COVID-19 and other coronaviruses based on the most up-to-date evidence. Even though remdesivir was proposed as a promising option for treating COVID-19 based on laboratory experiments and reports from compassionate use, its safety and effect in humans requires high-quality evidence from well-designed and adequately-powered clinical trials for further clarification.
SN - 1881-784X
UR - https://www.unboundmedicine.com/medline/citation/32378648/Rapid_review_for_the_anti_coronavirus_effect_of_remdesivir_
DB - PRIME
DP - Unbound Medicine
ER -